Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122876043 | 12287604 | 3 | F | 20090615 | 20160813 | 20160420 | 20160822 | EXP | FR-GILEAD-2016-0208893 | GILEAD | 60.00 | YR | A | Y | 50.00000 | KG | 20160822 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122876043 | 12287604 | 1 | PS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 1 DF, QD | Y | 21752 | 1 | DF | TABLET | QD | |||||
| 122876043 | 12287604 | 2 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 1 DF, EVERY TWO DAYS | Y | 21752 | 1 | DF | TABLET | ||||||
| 122876043 | 12287604 | 3 | C | HARVONI | LEDIPASVIRSOFOSBUVIR | 1 | Unknown | 0 | TABLET | ||||||||||
| 122876043 | 12287604 | 4 | C | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 122876043 | 12287604 | 5 | C | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | 0 | TABLET | |||||||||||
| 122876043 | 12287604 | 6 | C | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | UNK | 0 | ||||||||||
| 122876043 | 12287604 | 7 | C | DEPAKINE /00228501/ | VALPROIC ACID | 1 | Oral | UNK | 0 | ||||||||||
| 122876043 | 12287604 | 8 | C | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | UNK | 0 | ||||||||||
| 122876043 | 12287604 | 9 | C | VIDEX | DIDANOSINE | 1 | Oral | UNK | 0 | ||||||||||
| 122876043 | 12287604 | 10 | C | NORVIR | RITONAVIR | 1 | Unknown | 0 | |||||||||||
| 122876043 | 12287604 | 11 | C | EPIVIR | LAMIVUDINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122876043 | 12287604 | 1 | HIV infection |
| 122876043 | 12287604 | 2 | Hepatitis B |
| 122876043 | 12287604 | 3 | Hepatitis C |
| 122876043 | 12287604 | 4 | HIV infection |
| 122876043 | 12287604 | 5 | Hepatitis B |
| 122876043 | 12287604 | 6 | HIV infection |
| 122876043 | 12287604 | 7 | Epilepsy |
| 122876043 | 12287604 | 8 | HIV infection |
| 122876043 | 12287604 | 9 | HIV infection |
| 122876043 | 12287604 | 10 | Product used for unknown indication |
| 122876043 | 12287604 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122876043 | 12287604 | HO |
| 122876043 | 12287604 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122876043 | 12287604 | Fanconi syndrome acquired | |
| 122876043 | 12287604 | Glomerulonephritis | |
| 122876043 | 12287604 | Nephrectomy | |
| 122876043 | 12287604 | Nephropathy | |
| 122876043 | 12287604 | Renal cancer | |
| 122876043 | 12287604 | Renal failure | |
| 122876043 | 12287604 | Renal impairment | |
| 122876043 | 12287604 | Renal tubular disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122876043 | 12287604 | 1 | 20070910 | 20120402 | 0 | |
| 122876043 | 12287604 | 2 | 20120403 | 201601 | 0 | |
| 122876043 | 12287604 | 4 | 20030131 | 20070910 | 0 | |
| 122876043 | 12287604 | 6 | 20030131 | 201508 | 0 | |
| 122876043 | 12287604 | 7 | 2000 | 0 | ||
| 122876043 | 12287604 | 8 | 201508 | 0 | ||
| 122876043 | 12287604 | 9 | 20030131 | 20070910 | 0 |